Welcome to the international HTA database

Showing [16495 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2013	Health Quality Ontario (HQO)	Deep brain stimulation for treatment-resistant depression: a preliminary evidence review
2013	University of York	Evidence briefing on non-pharmacological interventions for dementia in care home settings
2013	Institute for Clinical and Economic Review (ICER)	Cardiac nuclear imaging
2013	Health Quality Ontario (HQO)	OHTAC recommendation: deep brain stimulation for treatment-resistant depression
2013	University of York	Telehealth for patients with long term conditions
2013	Institute for Clinical and Economic Review (ICER)	Cervical spinal fusion for degenerative disc disease
2013	Health Quality Ontario (HQO)	OHTAC recommendation: endovascular ablation for varicose veins
2013	NIHR Horizon Scanning Centre (NIHR HSC)	The SurroSense Rx™ System for prevention of diabetic foot ulcers
2013	University of York	Evidence briefing on urgent care systems
2013	Health Quality Ontario (HQO)	Appropriateness phase 1 OHTAC recommendations: annual health exams, aspartate aminotransferase testing, chloride testing, creatine kinase testing, ferritin testing, folate testing, and vitamin B12 testing
2013	NIHR Horizon Scanning Centre (NIHR HSC)	ATI™ Neurostimulation System for cluster headache
2013	University of York	Consolidating urgent care services
2013	Health Quality Ontario (HQO)	OHTAC recommendation: midurethral slings for women with stress urinary incontinence
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Ellex 2RT™ for early age-related macular degeneration
2013	University of York	Advance care planning
2013	Agency for Healthcare Research and Quality (AHRQ)	Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer
2013	NIHR Horizon Scanning Centre (NIHR HSC)	OssDsign™ Cranio PSI for skull repair
2013	University of York	Primary care 'in-reach' in hospital settings
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for cognitive impairment in older adults: an evidence update for the U.S. Preventive Services Task Force.
2013	NIHR Horizon Scanning Centre (NIHR HSC)	SmartSensor electronic oral glucose tolerance test for screening for diabetes
2013	Medical Services Advisory Committee (MSAC)	Testing for V600 status in patients with locally advanced or metastatic melanoma for access to appropriate therapies
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for lung cancer: systematic review to update the U.S. Preventive Services Task Force Recommendation
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Smart-Glasses depth-based visual aids for the partially sighted
2013	Medical Services Advisory Committee (MSAC)	Cell enrichment liquid based cytology (LBC) in routine screening for the prevention of cervical cancer
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Full Sense™ device for obesity
2013	Medical Services Advisory Committee (MSAC)	Transcatheter closure of patent ductus arteriosus
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening tools to identify adults with mild cognitive impairment not associated with dementia: a review of diagnostic accuracy, effectiveness and guidelines
2013	Medical Services Advisory Committee (MSAC)	Epidermal Growth Factor Receptor (EGFR) testing to determine eligibility for afatinib treatment in patients with locally advanced or metastatic non-small-cell lung cancer.
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Mini C-arm imagers for the follow-up of orthopedic patients: clinical effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dressings and care of skin graft sites: a review of clinical evidence and guidelines
2013	Medical Services Advisory Committee (MSAC)	Matrix-induced autologous chondrocyte implant
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Drugs for rare diseases: evolving trends in regulatory and health technology assessment perspectives
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Optimal care of chronic, non-healing, lower extremity wounds: a review of clinical evidence and guidelines
2013	Medical Services Advisory Committee (MSAC)	Sexual health medicine consultation items
2013	Adelaide Health Technology Assessment (AHTA)	Australian guidelines for the treatment of acute stress disorder and posttraumatic stress disorder
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Copper intra-uterine devices as a contraceptive for adult women: a review of clinical effectiveness and safety
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Naloxone for use in long-term care and palliative care: clinical effectiveness, safety, and guidelines
2013	Medical Services Advisory Committee (MSAC)	Addiction medicine consultation items
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Side rails on beds in long-term and residential care facilities: safety and evidence based guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Interventions for the prevention or management of childhood obesity: a review of the clinical evidence
2013	Medical Services Advisory Committee (MSAC)	Genetic testing for hereditary mutations in the RET gene
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Pomalidomide (Pomalyst®) for the treatment of refractory multiple myeloma or relapsed and refractory multiple myeloma
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Photo-activated disinfection therapy for dental surgery: review of the clinical effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transobturator slings for urinary incontinence: clinical effectiveness and guidelines
2013	Medical Services Advisory Committee (MSAC)	Implantation of fiducial markers into the prostate gland or prostate surgical bed for external beam radiotherapy
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Regorafenib (Stivarga®) in pts with metastatic colorectal cancer (CRC) who have progressed after standard therapy
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Antipsychotics for the management of agitation in adults with personality disorders or cognitive impairment: a review of the clinical effectiveness and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Removal of physical restraints in long term care settings: clinical safety and harm
2013	Medical Services Advisory Committee (MSAC)	Gene expression profiling of 21 genes in breast cancer to quantify the risk of disease recurrence and predict adjuvant chemotherapy benefit
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Heating standards for clinical interventions: clinical evidence
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Computed tomography angiography versus computed tomography for the diagnosis and management of hyperacute stroke: a review of comparative clinical evidence and guidelines
2013	Medical Services Advisory Committee (MSAC)	Codependent with PBAC- intravesical injection of botulinum toxin (Botox) into the bladder wall for urinary incontinence due to idiopathic overactive bladder
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcendental meditation for posttraumatic stress disorder, depression, and anxiety: a review of clinical effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bioabsorbable stents for adults with coronary artery disease: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2013	Medical Services Advisory Committee (MSAC)	Diagnostic fluorescence in situ hybridisation (FISH) testing for Anaplastic Lymphoma Kinase (ALK) in advanced non-small cell lung cancer (NSCLC) to determine eligibility for crizotinib treatment (co-dependent)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	GreenLight laser for the treatment of benign prostatic hypertrophy: a review of clinical and cost-effectiveness, and safety
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Diabetes screening for asymptomatic adults: a review of the diagnostic accuracy, cost effectiveness, and guidelines
2013	Medical Services Advisory Committee (MSAC)	Insertion, replacement, or removal of a cardiac resynchronisation therapy device capable of defibrillation (CRT-D) for mild, moderate or severe chronic heart failure (NYHA II, III or IV)
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Dabrafenib (Tafinlar®) in previously untreated subjects with BRAF mutation-positive advanced (stage III) or metastatic (stage IV) melanoma
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Management of congestive heart failure in primary and community care: guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fluconazole administration for the treatment of ductal yeast enfections: clinical effectiveness and safety
2013	Medical Services Advisory Committee (MSAC)	Single balloon enteroscopy
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Procedures and tools for patients at risk for creutzfeldt-jakob disease: guidelines and identification
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Nutritional supplementation for patients with cancer: clinical effectiveness and guidelines
2013	Medical Services Advisory Committee (MSAC)	Optical coherence tomography, for the diagnosis and monitoring of treatment effectiveness with aflibercept in patients with central retinal vein occlusion (co-dependent)
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Evidence requirements for the authorization and reimbursement of high-risk medical devices in the USA, Europe, Australia and Canada: an analysis of seven high-risk medical devices
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Nd:YAG laser for the treatment of patients with hidradenitis suppurativa: a review of the clinical effectiveness, cost-effectiveness, and safety
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Non-surgical debridement for chronic lower extremity wounds: clinical effectiveness and guidelines
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Linagliptin (Trajenta®) 5 mg film-coated tablets
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Abuse and misuse potential of drugs for attention deficit/hyperactivity disorder: a review of the clinical evidence
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Kidney transplantation following cardiocirculatory death: a review of the clinical evidence and guidelines
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Glycopyrronium bromide (Seebri® Breezhaler®) 44 micrograms inhalation powder as hard capsules
2013	Technology Assessment Unit of the McGill University Health Centre (MUHC)	The effectiveness and safety of rituximab (anti-CD20) in neurologic autoimmune diseases
2013	NIHR Health Technology Assessment programme	Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: a systematic review and economic evaluation
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Non-steroidal anti-inflammatory drugs for pain: a review of safety
2013	HAYES, Inc.	Autologous Stem Cell Transplantation (ASCT) for Metastatic Primitive Neuroectodermal Tumor (PNET)
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Quality of evidence in a systematic review on early skin-to-skin contact for mothers and their healthy newborn infants
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Lymphatic-Venous anastomosis for lymphedema: clinical and cost-effectiveness
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Aztreonam lysine (Cayston®) 75 mg powder and solvent for nebuliser solution
2013	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Transcatheter aortic valve implantation (TAVI) in patients with aortic stenosis. Update of Report No. 45
2013	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tuberculosis testing for correctional staff: diagnostic accuracy and guidelines
2013	HAYES, Inc.	Automated percutaneous lumbar discectomy
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Guidelines for initiating antiretroviral therapy in hospital inpatients with HIV
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Prostate cancer screening: a review of the guidelines
2013	Belgian Health Care Knowledge Centre (KCE)	Correction of refractive errors of the eye in adults – Part 2: laser surgery and intraocular lenses
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Urine drug screening in chronic pain patients on opioid therapy
2013	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Surgical aortic valve replacement with the ATS Enable® sutureless aortic valve for aortic stenosis
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Battery replacement and maintenance of deep brain stimulators: guidelines and recommendations
2013	HAYES, Inc.	Bilevel positive airway pressure for the treatment of obstructive sleep apnea in adults
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Thromboelastography-guided heparin use for the prevention of venous thromboembolism
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pain management for pediatric patients in the emergency department: guidelines
2013	Belgian Health Care Knowledge Centre (KCE)	Dissemination and implementation of clinical practice guidelines in Belgium
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Effects of non-steroidal anti-inflammatory drugs (NSAIDs) on bone fracture healing
2013	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Renal denervation for resistant hypertension
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Misoprostol administration for the treatment of post-partum uterine atony: clinical effectiveness, safety, and guidelines
2013	HAYES, Inc.	Biological mesh for abdominal hernia repair
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Antihistamine agents added to opioid analgesia
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bladder instillation of gentamicin for the treatment of recurrent urinary tract infections: clinical evidence and guidelines
2013	Belgian Health Care Knowledge Centre (KCE)	General framework for a multidisciplinary quality manual for cardiac care networks